MicroRNA‑mediated approaches in ovarian cancer therapy: A comprehensive systematic review
Oncology Letters · 12.08.2024 · 28 (4)
DOI: 10.3892/ol.2024.14624 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Oncology Letters, online erschienen am 12.08.2024. Verfasst von Henny Meitri Andrie Rachmasari Putri und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Indonesia Army Hospital, Central Jakarta 10410, Indonesia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Ovarian cancer (OC) poses a significant health risk to women worldwide, with late diagnoses and chemotherapy resistance leading to high mortality rates. Despite several histological subtypes, the primary challenge remains the subtle nature of its symptoms, resulting in advanced-stage diagnosis and reduced treatment success rates. With platinum-based therapies showing relative efficacy but limited survival enhancements, the emergence of chemotherapy resistance during recurrence remains a critical obstacle. Precision medicine development has aimed to address these challenges in the context of the molecular diversity of OC. The present review explored the landscape of microRNA (miRNA)-mediated approaches in OC treatment. miRNAs have emerged as regulators of gene expression, serving as both oncogenes and tumor suppressors in OC. Dysregulated miRNAs are associated with disease progression and chemotherapy resistance, underscoring their significance in diagnosis and tailored treatment strategies. The present review extracted 295 publications from the PUBMED database. Out of the 73 eligible studies, 55 miRNAs were assessed. A total of three of these miRNAs were not associated with any disease or cancer, whilst eight were associated with OC, albeit also associated with other diseases. The present review encompassed three dimensions: i) The role of miRNAs in treatment efficacy; ii) the use of miRNAs to enhance therapy outcomes; and iii) adjunctive strategies for improved treatment results. Furthermore, it offered insights into potential avenues for improving OC treatment using miRNA-based approaches.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Indonesia Army Hospital, Central Jakarta 10410, Indonesia.
- Siena Clinical, Central Jakarta 10340, Indonesia.
- Department of Obstetrics and Gynecology, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Depok, Yogyakarta 55281, Indonesia.
- Department of Obstetrics and Gynecology, Sardjito Hospital, Depok, Yogyakarta 55281, Indonesia.
- Department of Histology and Cell Biology, Faculty of Medicine, Public Health and Nursing, Gadjah Mada University, Depok, Yogyakarta 55281, Indonesia.
Zitieren
APA
Putri, H. M. A. R., Novianti, P. W., Pradjatmo, H., & Haryana, S. M. (2024). MicroRNA‑mediated approaches in ovarian cancer therapy: A comprehensive systematic review. Oncology Letters, 28(4). https://doi.org/10.3892/ol.2024.14624
Vancouver
Putri HMAR, Novianti PW, Pradjatmo H, Haryana SM. MicroRNA‑mediated approaches in ovarian cancer therapy: A comprehensive systematic review. Oncology Letters. 2024;28(4). doi:10.3892/ol.2024.14624
BibTeX
@article{Putri2024,
author = {Putri, Henny Meitri Andrie Rachmasari and Novianti, Putri Wikie and Pradjatmo, Heru and Haryana, Sofia Mubarika},
title = {MicroRNA‑mediated approaches in ovarian cancer therapy: A comprehensive systematic review},
journal = {Oncology Letters},
year = {2024},
volume = {28},
number = {4},
doi = {10.3892/ol.2024.14624}
}
EUVIMED